Nifty
Sensex
:
:
11930.35
40685.50
33.90 (0.28%)
127.01 (0.31%)

Pharmaceuticals & Drugs - Global

Rating :
49/99  (View)

BSE: 532649 | NSE: NECLIFE

20.30
0.15 (0.74%)
23-Oct-2020 | 3:56PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  20.70
  •  20.70
  •  20.20
  •  20.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  194237
  •  39.43
  •  30.05
  •  7.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 456.37
  • 385.45
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,213.84
  • 0.25%
  • 0.41

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 55.80%
  • 16.69%
  • 22.06%
  • FII
  • DII
  • Others
  • 2.9%
  • 0.00%
  • 2.55%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.34
  • 7.15
  • 8.04

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -0.33
  • -1.65
  • -1.43

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -11.19
  • -10.13
  • -15.27

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.74
  • 11.59
  • 8.80

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.62
  • 0.61
  • 0.43

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.41
  • 5.75
  • 5.39

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
390
639
-39%
565
0
0
648
733
-12%
579
724
-20%
Expenses
373
577
-35%
511
0
0
592
667
-11%
531
659
-20%
EBITDA
17
62
-73%
54
0
0
56
65
-14%
48
64
-26%
EBIDTM
4%
10%
9%
0%
8%
8%
7%
8%
Other Income
1
2
-76%
0
0
0
1
2
-62%
1
1
-18%
Interest
28
31
-11%
31
0
0
31
36
-14%
33
44
-25%
Depreciation
15
16
-8%
15
0
0
15
17
-10%
14
16
-11%
PBT
-26
16
-
8
0
0
10
14
-26%
3
7
-62%
Tax
-9
3
-
1
0
0
2
3
-32%
0
1
-83%
PAT
-17
14
-
7
0
0
8
11
-25%
2
6
-58%
PATM
-4%
2%
1%
0%
1%
1%
0%
1%
EPS
-0.95
0.77
-
0.42
0.00
0
0.46
0.61
-25%
0.14
0.33
-58%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
-
2,366
2,783
1,876
1,644
1,676
1,644
1,638
1,626
1,313
1,062
Net Sales Growth
-
-15%
48%
14%
-2%
2%
0%
1%
24%
24%
 
Cost Of Goods Sold
-
1,859
2,218
1,367
1,154
1,174
1,141
1,155
1,142
907
711
Gross Profit
-
508
565
509
489
502
502
484
484
406
351
GP Margin
-
21%
20%
27%
30%
30%
31%
30%
30%
31%
33%
Total Expenditure
-
2,147
2,519
1,640
1,419
1,437
1,377
1,350
1,336
1,065
835
Power & Fuel Cost
-
93
103
92
75
88
80
66
61
42
34
% Of Sales
-
4%
4%
5%
5%
5%
5%
4%
4%
3%
3%
Employee Cost
-
78
77
75
76
78
59
48
46
44
34
% Of Sales
-
3%
3%
4%
5%
5%
4%
3%
3%
3%
3%
Manufacturing Exp.
-
47
50
53
53
40
37
34
34
30
24
% Of Sales
-
2%
2%
3%
3%
2%
2%
2%
2%
2%
2%
General & Admin Exp.
-
20
22
23
20
20
22
22
18
17
13
% Of Sales
-
1%
1%
1%
1%
1%
1%
1%
1%
1%
1%
Selling & Distn. Exp.
-
46
46
29
39
35
35
25
30
18
15
% Of Sales
-
2%
2%
2%
2%
2%
2%
2%
2%
1%
1%
Miscellaneous Exp.
-
4
3
2
2
1
3
1
5
7
15
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0%
1%
0%
EBITDA
-
220
264
236
224
239
267
288
290
249
227
EBITDA Margin
-
9%
9%
13%
14%
14%
16%
18%
18%
19%
21%
Other Income
-
4
6
6
23
6
20
13
16
13
13
Interest
-
126
148
115
117
123
126
138
115
115
74
Depreciation
-
61
63
64
62
57
77
84
76
61
46
PBT
-
37
59
63
67
64
85
78
115
85
120
Tax
-
6
11
10
12
10
18
16
29
12
16
Tax Rate
-
15%
19%
17%
18%
15%
22%
21%
25%
14%
13%
PAT
-
32
48
52
55
54
66
62
86
73
104
PAT before Minority Interest
-
32
48
52
55
54
66
62
86
73
104
Minority Interest
-
0
0
0
0
0
0
0
0
0
0
PAT Margin
-
1%
2%
3%
3%
3%
4%
4%
5%
6%
10%
PAT Growth
-
-33%
-9%
-6%
2%
-18%
7%
-28%
17%
-30%
 
EPS
-
1.78
2.67
2.93
3.10
3.04
3.72
3.48
4.81
4.11
5.84

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
1,136
1,105
1,059
1,007
954
958
927
868
784
721
Share Capital
22
22
22
22
22
22
22
22
22
22
Total Reserves
1,114
1,083
1,036
984
932
936
905
845
762
699
Non-Current Liabilities
249
300
356
296
362
397
341
362
432
289
Secured Loans
120
164
218
161
243
264
223
260
363
234
Unsecured Loans
1
1
2
3
2
1
1
0
1
1
Long Term Provisions
8
9
9
8
7
6
5
4
3
2
Current Liabilities
1,248
1,300
1,309
1,279
1,240
1,156
1,126
1,045
904
803
Trade Payables
527
484
539
528
497
456
440
383
194
140
Other Current Liabilities
95
170
123
107
108
90
87
131
130
246
Short Term Borrowings
620
636
634
630
627
595
580
509
565
330
Short Term Provisions
6
10
12
13
8
14
19
22
15
87
Total Liabilities
2,633
2,705
2,724
2,581
2,556
2,510
2,394
2,274
2,121
1,813
Net Block
785
825
852
881
906
934
948
914
858
736
Gross Block
1,509
1,490
1,456
1,364
1,384
1,451
1,341
1,223
1,091
909
Accumulated Depreciation
724
666
604
482
478
518
394
309
234
173
Non Current Assets
1,018
1,036
1,063
1,085
1,092
1,106
1,157
1,123
1,071
869
Capital Work in Progress
115
100
100
102
99
91
122
139
150
82
Non Current Investment
0
0
0
0
0
0
0
0
0
0
Long Term Loans & Adv.
115
108
104
97
82
80
87
70
63
50
Other Non Current Assets
3
3
7
5
4
0
0
0
0
0
Current Assets
1,615
1,669
1,661
1,496
1,464
1,369
1,237
1,151
1,050
944
Current Investments
0
1
1
0
1
0
0
0
0
5
Inventories
978
918
859
855
837
791
758
676
591
471
Sundry Debtors
396
559
612
500
491
446
377
349
304
311
Cash & Bank
21
21
9
13
37
33
10
6
26
33
Other Current Assets
220
72
55
54
99
98
92
119
128
124
Short Term Loans & Adv.
150
99
125
74
68
85
69
87
105
102
Net Current Assets
367
369
351
217
224
213
111
106
145
141
Total Assets
2,633
2,705
2,724
2,581
2,556
2,510
2,394
2,274
2,121
1,813

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
285
239
65
199
169
144
255
361
165
44
PBT
37
59
63
67
65
85
78
115
85
120
Adjustment
186
207
176
159
174
185
213
180
157
122
Changes in Working Capital
70
-13
-161
-20
-62
-119
-16
68
-64
-186
Cash after chg. in Working capital
294
253
78
206
177
151
275
363
178
56
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
-9
-14
-13
-7
-9
-6
-20
-2
-13
-13
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
-33
-26
-29
-18
-77
-60
-90
-99
-234
-169
Net Fixed Assets
-34
-34
-90
17
60
-79
-102
-120
-250
-182
Net Investments
0
0
0
0
-1
0
0
0
5
20
Others
0
8
61
-35
-136
20
12
22
11
-7
Cash from Financing Activity
-252
-201
-40
-204
-89
-61
-161
-282
62
123
Net Cash Inflow / Outflow
0
12
-4
-23
3
23
4
-20
-7
-2
Opening Cash & Equivalents
21
9
13
37
33
10
6
26
33
35
Closing Cash & Equivalent
21
21
9
13
37
33
10
6
26
33

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
51
49
47
45
43
41
41
39
35
32
ROA
1%
2%
2%
2%
2%
3%
3%
4%
4%
6%
ROE
3%
4%
5%
6%
6%
7%
7%
10%
10%
16%
ROCE
8%
10%
9%
10%
10%
12%
12%
13%
12%
14%
Fixed Asset Turnover
1.76
2.11
1.48
1.27
1.26
1.25
1.33
1.45
1.35
1.35
Receivable days
66
69
97
104
95
86
78
71
83
87
Inventory Days
131
104
149
177
166
162
153
138
143
141
Payable days
82
69
114
128
119
113
106
76
55
56
Cash Conversion Cycle
114
104
132
153
142
134
125
133
172
172
Total Debt/Equity
0.69
0.82
0.90
0.87
1.01
1.00
0.93
1.01
1.33
1.10
Interest Cover
1
1
2
2
2
2
2
2
2
3

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.